LISATA THERAPEUTICS, INC. Operating Lease, Weighted Average Discount Rate, Percent
LISATA THERAPEUTICS, INC. (LSTA) had Operating Lease, Weighted Average Discount Rate, Percent of 0.00% as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-03-12
- 2025-09-30: Operating Lease, Weighted Average Discount Rate, Percent 0.00%.
- 2025-06-30: Operating Lease, Weighted Average Discount Rate, Percent 9.63%.
- 2025-03-31: Operating Lease, Weighted Average Discount Rate, Percent 9.63%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 9.63%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-09-30 | 0.00% 10-Q · filed 2025-11-06 |
| 2025-06-30 | 9.63% 10-Q · filed 2025-08-07 |
| 2025-03-31 | 9.63% 10-Q · filed 2025-05-08 |
| 2024-12-31 | 9.63% 10-K · filed 2026-03-12 |
| 2024-09-30 | 9.63% 10-Q · filed 2024-11-12 |
| 2024-06-30 | 9.63% 10-Q · filed 2024-08-12 |
| 2024-03-31 | 9.63% 10-Q · filed 2024-05-09 |
| 2023-12-31 | 9.63% 10-K · filed 2025-02-27 |
| 2023-09-30 | 9.63% 10-Q · filed 2023-11-02 |
| 2023-06-30 | 9.63% 10-Q · filed 2023-08-14 |
| 2023-03-31 | 9.63% 10-Q · filed 2023-05-09 |
| 2022-12-31 | 9.63% 10-Q · filed 2023-11-02 |
| 2022-09-30 | 9.63% 10-Q · filed 2022-11-10 |
| 2022-06-30 | 9.63% 10-Q · filed 2022-08-04 |
| 2022-03-31 | 9.63% 10-Q · filed 2022-05-05 |
| 2021-12-31 | 9.63% 10-K · filed 2022-03-22 |
| 2021-09-30 | 9.63% 10-Q · filed 2021-11-04 |
| 2021-06-30 | 9.63% 10-Q · filed 2021-08-05 |
| 2021-03-31 | 9.63% 10-Q · filed 2021-05-06 |
| 2020-12-31 | 9.63% 10-K · filed 2021-02-25 |
| 2020-09-30 | 9.63% 10-Q · filed 2020-11-05 |
| 2020-06-30 | 9.63% 10-Q · filed 2020-08-13 |
| 2020-03-31 | 9.63% 10-Q · filed 2020-05-07 |
| 2019-12-31 | 9.63% 10-K · filed 2020-03-05 |
| 2019-09-30 | 9.63% 10-Q · filed 2019-11-06 |
| 2019-06-30 | 9.63% 10-Q · filed 2019-08-08 |
| 2019-03-31 | 9.63% 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |